Patents for A61P 17 - Drugs for dermatological disorders (106,455)
04/1995
04/06/1995CA2172601A1 Perfluorocarbons as anti-inflammatory agents
04/06/1995CA2167526A1 Monoglyceride/lactate ester permeation enhancer
04/06/1995CA2165802A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin
04/06/1995CA2133614A1 Retinol containing anhydrous and stable cosmetic or pharmaceutical composition for skin and use thereof for the treatment of skin diseases
04/05/1995EP0646593A1 Corticoid-17,21-dicarboxylic acid ester and corticosteroid-17-carboxylic acid ester-21-carbonic, process for their production and medicaments containing them
04/05/1995EP0646576A1 Vitamin D3-analogs
04/05/1995EP0646371A1 Anhydrous cosmetic or pharmaceutical composition containing retinol
04/05/1995EP0646012A1 Wound healing and treatment of fibrotic disorders
03/1995
03/30/1995WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/30/1995WO1995008565A1 Use of angiotensin ii analogs in tissue repair
03/30/1995WO1995008555A1 2',5'-oligoadenylate-2',3'-cyclophosphates
03/30/1995WO1995008535A1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents
03/30/1995WO1995008338A1 Method for the treatment or prevention of eczema/dermatitis
03/30/1995WO1995008337A1 Use of angiotensin iii and analogs thereof in tissue repair
03/30/1995WO1995008325A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease
03/30/1995CA2172605A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease
03/30/1995CA2172494A1 Use of angiotensin ii analogs in tissue repair
03/30/1995CA2172491A1 Method for the treatment or prevention of eczema/dermatitis
03/30/1995CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/29/1995EP0645141A1 Treating water for dermatoses in domestic animals
03/29/1995EP0644766A1 Nitrous oxide containing dermatological composition
03/29/1995EP0644764A1 Lipids for epidermal moisturization and repair of barrier function
03/29/1995EP0644716A1 Medical uses of trioxolane and diperoxide compounds
03/28/1995US5401777 Use of preparations of curcuma plants
03/28/1995US5401773 Treating comedones
03/28/1995US5401770 Antipruritic agents and antipruritic compositions thereof
03/28/1995US5401733 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
03/28/1995US5401517 Cosmetic method for treatment of skin
03/28/1995CA1334936C Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
03/23/1995WO1995007985A1 Eotaxin: eosinophil chemotactic cytokine
03/23/1995WO1995007710A1 Remedy for wound
03/23/1995WO1995007692A1 Viscous surfactant emulsion compositions
03/23/1995WO1995004142A3 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
03/23/1995WO1994028897A3 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
03/23/1995CA2149323A1 Therapeutic agent for treating wounds
03/22/1995EP0643959A1 Use of 13-transretinoic acid esters for the treatment of skin cancer and photoaging
03/22/1995EP0643712A1 Spiro-oxetanes, process for preparing the same and medicaments
03/22/1995EP0557301B1 5-fluoro-2,4,6-pyrimidinetriamine compounds for preventing hair loss
03/21/1995US5399698 Quinolin-2-yl-methoxybenzylhydroxyureas
03/21/1995US5399694 Antitumor
03/21/1995US5399590 Treatment of skin tumors, rheumatic diseases
03/21/1995US5399563 Benzylidenequinuclidinones
03/21/1995US5399561 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity
03/21/1995CA1334850C Ureylene-2,4,6-pyrimidine-3-oxide derivatives, their preparation and use in cosmetics and dermopharmacy
03/21/1995CA1334847C Oxadiazolopyrimidones, their preparation and application in cosmetics and dermopharmacy
03/16/1995WO1995007091A1 Uses of vegetable oils
03/16/1995WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/15/1995EP0642516A1 Macrocyclic immunomodulators
03/15/1995EP0642513A1 Indolocarbazole imides and their use
03/15/1995EP0642499A1 Retinoids and their use in treating skin diseases and leukemia
03/15/1995EP0642351A1 New pharmaceutical uses of krill enzymes
03/15/1995EP0642346A1 Solid, storage-stable, germicidal, pre-iodine composition
03/15/1995EP0558509B1 Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, dermatological compositions in particular, helping renew the epidermis, stimulating regrowth of hair, or delaying hair loss
03/15/1995EP0394333B1 Uses of sulphated sugars
03/15/1995CN1099982A Medicine for treatment of leukoderma and its preparing method
03/14/1995US5397775 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26,27-dimethylene-24-epi-1α,25-dihydroxyvitamin D2 and methods for preparing same
03/14/1995CA1334759C N,n'-diaminocarbonylmethyl-n,n'-dicarboxymethyl-1,2- diaminoethane derivatives
03/14/1995CA1334751C Ureylene-2,4,6-pyrimidine-3-oxide derivatives, their preparation and use in cosmetics and dermopharmacy
03/09/1995WO1995006457A1 Compositions against skin impurities and mild forms of acne containing lanolinic acid or lanolinic acid components as active substance
03/08/1995EP0641759A1 Aromatic carboxylic acid derivatives, their preparation and drugs containing these derivatives
03/08/1995EP0641557A1 Dermatologic or cosmetic composition made up by an oil in water emulsion based on oily globules coated with a lamellar liquid crystall coating
03/08/1995EP0641223A1 Biotherapeutic cell-coated microspheres
03/08/1995EP0641201A1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids
03/08/1995CN1099604A Hair lotion
03/07/1995US5395842 Inhibitors of sex steroids
03/07/1995US5395624 Depigmenting cosmetic and/or dermatological composition containing a di- or tri-caffeoylquinic acid, or a mixture thereof
03/07/1995CA1334656C Esterified oligosaccharides having uronic acid and hexosamine residues
03/02/1995WO1995006020A1 New diphenylhexene
03/02/1995WO1995005852A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections
03/02/1995WO1995005829A1 Therapeutic system for treating psoriasis
03/02/1995CA2168882A1 Therapeutic system for treating psoriasis
03/01/1995EP0640616A2 17-Alkylcarbonate, 21-0-carbonic/carboxylic acid esters of corticosteroids, a method for their production and pharmaceutical compositions containing them
03/01/1995EP0640352A1 Preparation of a skin surface for a surgical procedure
03/01/1995EP0640346A1 Uses of sulphated sugars against inflammation
03/01/1995EP0640342A2 Pentoxifylline and/or depogen for improving the tissue antioxidant status
03/01/1995EP0640340A1 Composition for accelerating healing of wound
03/01/1995EP0640129A1 Inhibition of cell adhesion protein-carbohydrate interactions
03/01/1995EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
03/01/1995CN1099265A Composition for accelerating healing of wound
03/01/1995CA2131224A1 Treating water for dermatoses in domestic animals
02/1995
02/28/1995US5393900 Steroid intermediates for the formation of vitamin D3 analogues
02/28/1995US5393792 High dosage topical forms of collagenase
02/28/1995US5393788 Administering in the treatment of asthma or an allergic or inflammatory disease
02/28/1995US5392725 Sewing machine needle and method for manufacturing same
02/28/1995CA2130015A1 Preparation of a skin surface for a surgical procedure
02/28/1995CA2028560C Methods and compositions employing certain lysozymes and endoglycosidases
02/23/1995WO1995005412A1 Cosmetic melanins
02/23/1995WO1995005375A1 Indole derivatives as 5-alpha-reductase-1-inhibitors
02/23/1995WO1995005191A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-β ACTIVITY
02/23/1995WO1995005155A1 Use of oligosaccharides for the prevention and treatment of tissue ageing
02/23/1995CA2590837A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity
02/23/1995CA2169360A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity
02/22/1995EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production
02/22/1995EP0639373A1 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
02/22/1995EP0639368A1 Scalp care product composition
02/22/1995EP0639224A1 Lectin domain variants of selectin
02/22/1995EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
02/22/1995EP0639073A1 Biologically active ureido derivatives useful as antimetastatic agents
02/22/1995EP0639068A1 Acne treating composition
02/22/1995EP0526502B1 Phenolic amine depigmenting and antimelanoma agents